Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.10.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.10.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.424ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.424ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.424ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.424NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.64ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.64NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.327ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.327ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4486.95China
B.1.1.327ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.327NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.396ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.396ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.396ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.396NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
B.1.1.129ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.129ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.129ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.129NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used